Top Research Reports for AstraZeneca, Accenture & AT&T
Todays Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), Accenture plc (ACN) and AT&T…
69,750$
-1,94%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca reports positive results for Airsupra v. albuterol study
…
AstraZeneca licenses lipid lowering Lp(a) asset
7 October 2024
AstraZeneca strengthens its cardiovascular pipeline with agreement for a pre-clinical novel lipid-lowering therapy
AstraZeneca has entered into an exclusive…
AstraZeneca and Gilead Sciences merger would be the biggest in the pharma history
…
Avillion announces positive high-level results from Phase III BATURA trial with AstraZeneca’s inhaled anti-inflammatory medication Airsupra in asthma patients
London, UK, 7 October 2024 – Avillion Life Sciences Ltd (“Avillion”) announces that the ongoing BATURA Phase IIIb trial evaluating…
5 Large Drug Stocks to Watch From a Thriving Industry
Drug and biotech companies are seeing significant innovation in 2024. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), AstraZeneca (AZN),…
AstraZenecas Calquence sNDA Gets FDA Priority Tag for Expanded Use
The FDA grants priority review to AZNs sNDA for Calquence for untreated mantle cell lymphoma. A decision is expected in…
Total Voting Rights
1 October 2024 15:00 BST
Transparency Directive
Voting rights and capital
The following notification is made in accordance with the UK Financial Conduct…
AstraZenecas Enhertu sBLA Gets FDA Priority Tag for Expanded Use
The FDA grants priority review to AZNs sBLA for Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer. A decision…
Novos Tough Month Key in Ending Health Stocks Winning Streak
European health-care stocks are set to snap their longest winning streak since March 2010, dragged down by concerns over Novo…